Aton Ra Partners Abbott Laboratories Transaction History

Aton Ra Partners

$50.1 Million
Q4 2023

A detailed history of Aton Ra Partners transactions in Abbott Laboratories stock. As of the latest transaction made, Aton Ra Partners holds 2,345 shares of ABT stock, worth $269,112. This represents 0.51% of its overall portfolio holdings.

Number of Shares

2,345

Previous 2,533 7.42%

Holding current value

$269,112

Previous $245,000 5.31%

% of portfolio

0.51%

Previous 0.51%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$90.19 - $110.4 $16,955 - $20,755	-188 Reduced 7.42%	2,345 $258,000
Q3 2023 Oct 25, 2023	SELL	$95.53 - $114.62 $9,648 - $11,576	-101 Reduced 3.83%	2,533 $245,000
Q2 2023 Jul 18, 2023	SELL	$100.78 - $112.29 $56,033 - $62,433	-556 Reduced 17.43%	2,634 $287,000
Q1 2023 May 05, 2023	SELL	$96.86 - $114.01 $43,490 - $51,190	-449 Reduced 12.34%	3,190 $323,000
Q4 2022 Feb 02, 2023	SELL	$95.06 - $111.52 $69,013 - $80,963	-726 Reduced 16.63%	3,639 $399,000
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $98,888 - $114,494	-1,022 Reduced 18.97%	4,365 $422,000
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $816,049 - $986,343	-7,995 Reduced 59.74%	5,387 $585,000
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $789,930 - $963,269	-6,928 Reduced 34.11%	13,382 $1.59 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $835,281 - $1.02 Million	7,230 Added 55.28%	20,310 $2.86 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $758,290 - $838,890	-6,500 Reduced 33.2%	13,080 $1.55 Million
Q2 2021 Aug 12, 2021	SELL	$105.79 - $124.53 $91,190 - $107,344	-862 Reduced 4.22%	19,580 $2.27 Million
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $320,098 - $377,124	-2,941 Reduced 12.58%	20,442 $2.45 Million
Q4 2020 Feb 19, 2021	BUY	$105.0 - $114.42 $2.46 Million - $2.68 Million	23,383 New	23,383 $2.56 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aton Ra Partners, based on Form 13F filings with the SEC.

News

Stay updated on Aton Ra Partners with notifications on news.

Account